2؉ -activated cation channel of the transient receptor potential superfamily, undergoes a fast desensitization to Ca 2؉ . The mechanisms underlying the alterations in Ca 2؉ sensitivity are unknown. Here we show that cytoplasmic ATP reversed Ca 2؉ sensitivity after desensitization, whereas mutations to putative ATP binding sites resulted in faster and more complete desensitization. Phorbol ester-induced activation of protein kinase C (PKC) increased the Ca 2؉ sensitivity of wildtype TRPM4 but not of two mutants mutated at putative PKC phosphorylation sites. Overexpression of a calmodulin mutant unable to bind Ca 2؉ dramatically reduced TRPM4 activation. We identified five Ca 2؉ -calmodulin binding sites in TRPM4 and showed that deletion of any of the three C-terminal sites strongly impaired current activation by reducing Ca 2؉ sensitivity and shifting the voltage dependence of activation to very positive potentials. Thus, the Ca 2؉ sensitivity of TRPM4 is regulated by ATP, PKC-dependent phosphorylation, and calmodulin binding at the C terminus.
TRPM4, a Ca
2؉ -activated cation channel of the transient receptor potential superfamily, undergoes a fast desensitization to Ca 2؉ . The mechanisms underlying the alterations in Ca 2؉ sensitivity are unknown. Here we show that cytoplasmic ATP reversed Ca 2؉ sensitivity after desensitization, whereas mutations to putative ATP binding sites resulted in faster and more complete desensitization. Phorbol ester-induced activation of protein kinase C (PKC) increased the Ca 2؉ sensitivity of wildtype TRPM4 but not of two mutants mutated at putative PKC phosphorylation sites. Overexpression of a calmodulin mutant unable to bind Ca 2؉ dramatically reduced TRPM4 activation. We identified five Ca 2؉ -calmodulin binding sites in TRPM4 and showed that deletion of any of the three C-terminal sites strongly impaired current activation by reducing Ca 2؉ sensitivity and shifting the voltage dependence of activation to very positive potentials. Thus, the Ca 2؉ sensitivity of TRPM4 is regulated by ATP, PKC-dependent phosphorylation, and calmodulin binding at the C terminus.
TRPM4
1 is a Ca 2ϩ -activated and voltage-dependent Ca 2ϩ -impermeable cation channel with a unitary conductance of 25 picosiemens that belongs to the melastatin subfamily of transient receptor potential membrane proteins (1) (2) (3) (4) . Ca 2ϩ -activated, Ca 2ϩ -impermeable nonselective cation channels that share functional properties with expressed TRPM4 (or the closest homologue, TRPM5) have been found in many excitable and non-excitable cells (Refs. 5-8; for reviews, see Refs. 9 and 10). These nonselective channels may regulate important processes including cardiac rhythmicity and neural bursting activity, and their Ca 2ϩ -dependent activation has been suggested to form a general feedback control mechanism for Ca 2ϩ influx in nonexcitable cells.
The functional analysis of TRPM4 and TRPM5 and their comparison with native nonselective cation channels are complicated by a peculiar property of these channels: when activated by an increase in free intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), the currents decay rapidly due to a decrease in the sensitivity of the channels to Ca 2ϩ (1, 3, 4, 11) . Moreover, recent studies on TRPM4 exhibit an unusually large variability in reported values for Ca 2ϩ sensitivity and activation time courses (1) (2) (3) (4) . Most likely, these discrepancies reflect a highly regulated Ca 2ϩ affinity of TRPM4, which may be of physiological relevance.
Another puzzling property of TRPM4 is its sensitivity to ATP. We have shown recently that cytosolic ATP 4Ϫ acts as a potent inhibitor of TRPM4 currents in inside-out patches, with half-maximal inhibition at ϳ2 M (3). However, robust TRPM4 currents can be measured in the whole-cell mode, even under conditions in which the free cytosolic ATP 4Ϫ concentration exceeds 100 M. One possible explanation of this apparent paradox could be that ATP has both an inhibitory and a stimulatory effect on TRPM4, but experimental data to support this idea are currently lacking.
In the present study, we investigated potential cellular factors that influence Ca 2ϩ -dependent activation of TRPM4. We report that the Ca 2ϩ sensitivity of TRPM4 is regulated by cytosolic ATP, protein kinase C (PKC)-dependent phosphorylation, and calmodulin (CaM), and we identify distinct residues in the channel protein that are crucial for the modulation by these cellular factors.
MATERIALS AND METHODS
Cell Culture, Expression of TRPM4, and Mutagenesis-Human embryonic kidney HEK293 cells were grown in Dulbecco's modified Eagle's medium containing 10% (v/v) human serum, 2 mM L-glutamine, 2 units/ml penicillin, and 2 mg/ml streptomycin at 37°C in a humiditycontrolled incubator with 10% CO 2 .
For transient expression, we used the recombinant bicistronic expression plasmid pdiTRPM4b, which carries the entire protein-coding region for human TRPM4b (GenBank TM accession number AX443227; kindly provided by Drs. V. Flockerzi and U. Wissenbach) and for the green fluorescent protein (GFP) coupled by an internal ribosomal entry site sequence. HEK293 cells were transiently transfected with the pdiTRPM4b vector using methods described previously, and successfully transfected cells were visually identified by their green fluorescence in the patch clamp set up (for details, see ref. 4) . For experiments with the dominant negative CaM mutant, CaM 1,2,3,4 , we used tetracycline-inducible HEK293 cells expressing FLAG-TRPM4, which were cultured at 37°C with 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 2 mM glutamine, as described previously (1) . The medium was supplemented with blasticidin (5 g/ml; Invitrogen) and zeocin (0.4 mg/ml; Invitrogen). For all experiments, cells were treated with 1 g/ml tetracycline (Invitrogen) for 16 -24 h and used after 16 -20 Single amino acid mutations were done by using the standard PCR overlap extension technique (18) . A chimera containing the first intracellular linker of TRPM5 in the TRPM4 backbone was obtained using the overlap extension technique with human TrpM4 cDNA and mouse TrpM5 cDNA as templates; both were constructed in the pCAGGSM2/ IresGFP vector (12) . The chimerical overlap PCR fragments were replaced in pCAGGSM2/TrpM4/IresGFP using AscI/ClaI restriction enzymes. The nucleotide sequences of all mutants were verified by sequencing of the corresponding cDNAs. Fig. 1 provides an overview of the mutants and constructs used in this study.
CaM Binding Assay-Constructs for TRPM4 fragments fused to the C terminus of maltose-binding protein (MBP), in vitro synthesis of 35 S-labeled MBP fusion proteins, and assay conditions for their binding to CaM were essentially the same as those described previously (13, 14) .
Cell Surface Biotinylation Assay-In order to facilitate immunodetection of the expressed proteins, coding regions of TRPM4 and its C-terminal CaM site mutants were subcloned into pEGFP-C3 (Clontech). The resulting plasmids express TRPM4 and its mutants with GFP fused at the N termini. Transfection, biotinylation, and streptavidin precipitation were performed as described previously (15) . Immunoblotting was performed using anti-GFP antibodies (Clontech). Sample loading for the crude cell lysate and streptavidin-precipitated portion represents 12 and 355 g, respectively, of total proteins in cell lysates. Identical exposure time was used to reveal the chemiluminescent signals for the GFP fusion proteins in crude lysates and streptavidin-precipitated samples.
Solutions-The extracellular solution for cell attached measurements and the pipette solution for inside-out patch clamp measurements contained 156 mM NaCl, 5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES, buffered at pH 7.4 with NaOH. Before patch excision, the extracellular bath solution was changed to an "internal solution" for inside-out patch clamp, which contained 156 mM CsCl, 1 mM MgCl 2 , and 10 mM HEPES, pH 7.2 with CsOH. The Ca 2ϩ concentration at the inner side of the membrane was adjusted between 100 nM and 10 M by adding the appropriate amounts of CaCl 2 calculated by the CaBuf program (ftp://ftp.cc.kuleuven.ac.be/pub/droogmans/cabuf.zip) to the 10 mM EGTA-containing solution. For Ca 2ϩ concentrations between 100 M and 10 mM, CaCl 2 was added to an EGTA-free solution. In ATPcontaining pipette solutions, we always used 4 mM Na 2 ATP. Mg 2ϩ was added to obtain a free Mg 2ϩ concentration of 500 M, in which case the Mg-ATP concentration amounts to 3.6 mM.
The extracellular solution for whole-cell measurements contained 156 mM NaCl, 5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES, buffered at pH 7.4 with NaOH. The pipette solution contained 156 mM CsCl, 1 mM MgCl 2 , 10 mM HEPES, and 10 mM EGTA, pH 7.2 with CsOH. Ca 2ϩ concentration was adjusted between 100 nM and 100 M by adding appropriate amounts of CaCl 2 . Recombinant CaM was added to the internal solution (bath solution) in inside-out patch clamp experiments at a concentration of 10 M (diluted from a stock solution of 0.5 mM in 10 mM MOPS, pH 7.5, and 5 mM KCl).
Electrophysiology-Currents were monitored with an EPC-9 (HEKA Elektronik, Lambrecht, Germany). Patch electrodes had a DC resistance between 2 and 4 megaohms. An Ag-AgCl wire was used as a reference electrode. For whole-cell measurements, we used 400-ms ramps from Ϫ150 to ϩ100 mV (sample interval, 800 s; 512 points; 2-s interval between ramps; holding potential, 0 mV; series resistance compensation, 60 -80%). For inside-out patches, the sampling interval was 500 s, the interval between steps was 2 s (2048 points; filter setting, 1 kHz).
Step protocols for single channel measurements were applied from holding potentials of 0 mV and consisted of 400-ms steps to Ϫ100 mV followed by a step to ϩ100 mV. The interval between the pulses was 5 s. Experiments were performed at room temperature (22-25°C) .
Data Analysis-Electrophysiological data were analyzed using WinASCD software (G. Droogmans, Leuven, Belgium). Pooled data are given as the mean Ϯ S.E. of n cells. Significance was tested using Student's unpaired t test (p Ͻ 0.05).
RESULTS

ATP Restores the Ca
2ϩ Sensitivity of TRPM4 after Desensitization-In all patch-clamp configurations, an increase in [Ca 2ϩ ] i induced a fast activating, transient current in HEK293 cells that expressed TRPM4. Fig. 2A shows a typical time course of the whole-cell current activated by dialysis of a pipette solution that contained 10 M [Ca 2ϩ ] i but no ATP. The I-V curves obtained from the voltage ramps, measured at the times indicated by the solid points, display the typical rectification behavior of TRPM4 currents (1, 4) . The current was almost completely abolished within 2 min of cell dialysis (Fig. 2, A and B) . The same results were obtained when dialyzing the cells with 4 mM ATP and 0.5 mM free Mg 2ϩ (Fig. 2B ). In the inside-out configuration, currents measured in the absence of ATP also decayed rapidly to a sta- -free solution contained Mg-ATP. The latter currents were again followed by desensitization (Fig. 2, D and E) . . Inducible HEK293 FLAG-TRPM4 cells were used, which exhibit a smaller current density and a smaller current scattering than transiently transfected HEK293 cells. Voltage ramps from Ϫ100 to ϩ100 mV for 400 ms and with an interval of 2 s were applied from a holding potential of 0 mV. Time course on the left shows current development at ϩ100 (circles) and Ϫ100 (triangles) mV. The I-V curves taken at the time points indicated by the filled circles (black circle, peak; gray circle, 120 s after start of the dialysis) are plotted to the right. No ATP was present in the pipette solution. B, average whole-cell current density from 10 cells at ϩ100 mV measured at the peak and after 120 s of dialysis. Data obtained by inclusion of 4 mM ATP and 0.5 mM free Mg 2ϩ in the pipette solution were not significantly different from those obtained with 0 ATP. C, time course of current activated by 100 M Ca 2ϩ in inside-out patches. The current decayed to a "quasi"-stationary value (star). The traces to the right are from the times indicated by the larger symbols (black circle, peak current; star, steady state; gray circle, recovery after perfusion of the patch with Ca 2ϩ -free solution). Data points represent amplitudes of the initial current during the 500-ms step to Ϫ100 mV (triangles) and the currents measured at the end of the 250-ms step to ϩ100 mV (circles). Note that no recovery occurred after Ca 2ϩ reapplication. D, the same protocol as described in C. However, during the Ca 2ϩ -free perfusion, the solution containing 4 mM ATP and 500 M free Mg 2ϩ was applied as indicated. Note that after switching back to the 100 M Ca 2ϩ solution, the initial current was completely restored (symbols are as defined in C). E, pooled data showing the ratio between steady-state current (I ss ; stars) and peak current (black circle) as a black column and the ratio between recovered current (I recov ; gray circles) and peak current as a gray column (n ϭ 12 for 0 ATP, n ϭ 14 for 4 ATP, 0.5 Mg 2ϩ ).
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FIG. 3. Mutations to putative ATP binding sites accelerate the decay of Ca 2؉ -activated TRPM4 currents in inside-out patches.
A, the time course of TRPM4 currents was measured by the same step protocol as described in Fig. 2C (in inside-out patches perfused from the inner side with 300 M Ca 2ϩ ). Filled symbols indicate different time points during the decay, and current traces are superimposed (left) from the time course. Time courses of the wild type (circles) and L275C mutant (triangles) of TRPM4 currents at ϩ100 mV are superimposed and normalized to the peak values. From these plots, the time constant of decay () and the apparent steady-state open probability (P open,ss ) were calculated. Note the very fast decay for the L275C mutant (WB2) and the differences in kinetics in the superimposed traces. The slower activation of the mutant at ϩ100 mV is consistent with a decreased Ca 2ϩ sensitivity (2) . B, pooled data from four mutants and wild-type TRPM4. The time constant to reach the stationary current level and the apparent open probability in the stationary state (P open,ss ; steady-state current divided by the peak current) were
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Thus, ATP is able to restore Ca 2ϩ sensitivity after desensitization. We have shown previously that free ATP 4Ϫ , but not Mg-ATP, is an efficient blocker of TRPM4 channels (3). Therefore, ATP has a dual effect on TRPM4: its ionized form blocks the channel, whereas binding of ATP might have an effect on stabilizing or restoring the Ca 2ϩ sensitivity of the channel. We have therefore explored the latter hypothesis in more detail.
Direct Binding of ATP Is Important for Maintaining the Ca 2ϩ
Sensitivity of TRPM4 -Multiple ATP binding sites, including Walker B motifs and ABC transporter signature motifs (16, 17) , can be predicted from the TRPM4 amino acid sequence (Fig. 1) . In the N terminus, 231 AFFLVD (WB1) and 273 VLLL-LID (WB2) represent two Walker B motifs. An ABC transporter signature motif, 322 GSSGGARQGEARDR, is located in the vicinity of WB1 and WB2. Two other predicted Walker B motifs are present in the first intracellular loop between TM2 and TM3, 800 VLLVD (WB3) and 858 LYLAD (WB4). They are again coupled to an ABC transporter motif, 833 LSGGGGSLASSGG. Mutations of the WB2 site resulted in an extremely fast and more complete decay of the currents in inside-out patches, indicating that desensitization is accelerated. An example for the L275C mutation located in WB2 is given in Fig. 3A . The time course and the extent of the decay were quantified by the time constant () and the apparent open probability in the "stationary" phase (P open,ss ), respectively. In comparison with the wild-type channel, was reduced by 50%, whereas P open,ss was reduced by 95% for L275C (Fig. 3, A and B) . The same result was obtained for L275A (Fig. 3B) . Mutation of a neighboring negatively charged residue (Asp 279 ) or a nonpolar residue (Ile 278 ) to asparagine (D279N or I278N) did not affect the rate of decay or the stationary value (Fig. 3B) . These results indicate that the loss of the WB2 ATP binding site causes a more pronounced desensitization. Note that it was difficult to quantify the effects in many of these mutants (whole-cell as well as insideout conditions) due to the extremely fast current decay (ϳ10 s). In fact, whole-cell currents were hardly measurable. We have therefore focused experiments on inside-out patches.
Next, we mutated the first ABC transporter signature motif, which is located in the vicinity of WB2. A single amino acid substitution in this region, G325A, again accelerated the decay and completely abolished currents within ϳ10 s (Fig. 3, C and  D) . Mutation of neighboring residues, G324A and R327A, had no significant effect.
To investigate the role of WB3 and WB4, which are colocalized with the second ABC transporter signature motif in the first intracellular linker between TM2 and TM3, we exchanged the TM2-TM3 of TRPM4 with that of TRPM5, which lacks these motifs. Note that TRPM5 is not sensitive to ATP and is not blocked by ATP 4Ϫ (8) . Fig. 3E shows that for wildtype TRPM4, the currents decayed to a stationary value after patch excision in 100 M Ca 2ϩ . This decay is faster and more complete at negative potentials. The TRPM4/5 chimera that contained the TM2-TM3 linker of TRPM5 displayed an extremely fast and complete decay (Fig. 3F) . Data are summarized in Fig. 3G . Thus, exchanging the TM2-TM3 linker of TRPM4 with a sequence that does not contain the Walker B and ABC motifs resulted in a highly significant acceleration of the decay, indicating a much faster loss of Ca 2ϩ sensitivity (2) . Obviously, all mutations predicted to affect ATP binding to the channel caused a very fast and complete decay of the Ca 2ϩ -activated currents of TRPM4.
Interestingly, as shown in Fig. 3 , H and I, all mutants and the TRPM4/5 chimera showed a strongly reduced recovery after Ca 2ϩ -free perfusion with 4 mM ATP and 0.5 mM free Mg 2ϩ as compared with that of the wild type shown in Fig. 2D . (Fig. 1 ). First, we tested whether phosphorylation could modify channel activation. For this experiment, we dialyzed the cells with 1 M Ca 2ϩ , which only caused activation of whole-cell currents through TRPM4 channels in a small fraction of cells both in the absence and presence of 4 mM ATP (3 of 12 cells). Fig. 4A shows an example of a responding cell, in which current activation was induced by 1 M [Ca 2ϩ ] i in the absence of ATP. The activated currents are small and lack the typical outward rectification pattern of TRPM4 currents. Fig. 4D shows the averaged current amplitudes. Next, we tested the role of PKC by applying phorbol 12-myristate 13-acetate (PMA). Preincubation with 1 M PMA for 1 h significantly increased the incidence of TRPM4 current activation by 1 M Ca 2ϩ (7 of 10 cells). The whole-cell current densities resulting from activation by 1 M Ca 2ϩ were also significantly increased by the PMA pretreatment (Fig. 4, B and D) . The EC 50 value for Ca 2ϩ , as measured from the peak currents in the presence of 4 mM ATP and at various Ca 2ϩ concentrations, was 15 M in control cells (Fig.  4C ) compared with 4 M in cells preincubated with PMA (Fig.  4, B and C) . The effect of PMA was absent in cells expressing the mutants S1145A or S1152A (Fig. 4, C and D) . These findings indicate that PKC-dependent phosphorylation increases the Ca 2ϩ sensitivity of TRPM4. The nearly negligible effect of the presence and absence of ATP in the patch pipette may hint at the non-complete washout of ATP during ATP-free dialysis during the fast first peak of current activation.
CaM Is Involved in Conferring the Ca 2ϩ Sensitivity of TRPM4 -Next, we tried to find the molecular determinant(s) that transfers Ca 2ϩ sensitivity to TRPM4. We reasoned that either Ca 2ϩ could bind and activate the channels directly or the activation could proceed via Ca 2ϩ binding to an accessory Ca 2ϩ -binding protein such as CaM. To validate the second possibility, we have first studied on whole-cell currents the effect of overexpression of a dominant negative CaM mutant, CaM 1,2,3,4 , in which all four EF-hand Ca 2ϩ binding sites are measured. C, current traces obtained by continuous sampling at a holding potential of ϩ100 mV (sampling interval, 4 ms) in inside-out patches exposed to 300 M [Ca 2ϩ ] i . Traces were fitted with a single exponential (I ϭ a ϩ b ϫ exp(Ϫ/t; gray lines). Note the fast and complete current decay of the G325A mutant in the ABC transporter signature motif. D, pooled data from the experiments shown in C for the time constants of decay and P open,ss . G325A, but not the neighboring mutations G324A and R327A, shows significant reductions in both parameters (data from 10 cells in each group, for significance, p G324A,R327A versus p WT Ͼ 0.05 for and P open,ss , respectively). E, time course (right) and superimposed current traces (left) of wild-type (gray symbols) TRPM4 in inside-out patches exposed to 100 M [Ca 2ϩ ] i . Patches were held at 0 mV, stepped to Ϫ100 mV for 500 ms, and then stepped to ϩ100 mV for 250 ms. Filled symbols indicate different time points during the decay, and current traces are superimposed (left) from the time course. F, the same protocol as described in E, but for the TRPM4-TRPM5 chimera (TRPM4/5). Note the fast and complete decay. G, pooled data of the time constant of decay () measured and P open,ss at Ϫ100 and ϩ100 mV. Note the always faster decay at Ϫ100 mV than ϩ100 mV in wild-type TRPM4 (see also Ref.
2). The TRPM4/5 chimera shows a dramatically accelerated and complete desensitization (data are from six cells in each group). H, the same protocol as described in E. During the time indicated by the bar, 4 mM ATP and 0.5 mM free Mg 2ϩ were applied to an inside-out patch from the TRPM4/5 chimera. Note that after reapplication of Ca 2ϩ , no transient recovery appeared as compared with those shown in Fig. 2D . I, the reduced recovery from the same protocols as shown in H was measured in the L275C and G325A mutants. mutated. These experiments were performed in an inducible, hTRPM4-expressing HEK293 cell line (1, 3) . Transient expression of CaM 1,2,3,4 in these cells resulted in a drastic decrease of the current amplitude (Fig. 5, A and B) , although some TRPM4 activity was still detectable (Fig. 5C ). These data suggest that CaM may be involved in regulating TRPM4 activation.
In a second approach, we added recombinant CaM to the Ca 2ϩ -containing solution in which the inside-out patches were excised (100 M Ca 2ϩ and 10 M CaM). Desensitization was also seen in the presence of CaM (Fig. 5, D and E) . However, the ratio between inward current at Ϫ100 mV and ϩ100 mV was increased, and current decay was less pronounced than in the absence of CaM (Fig. 5, FϪH) . These data indicate that in cell-free patches, CaM reduced desensitization of TRPM4.
We then searched for CaM-binding sites on TRPM4 using in vitro binding assays. Fragments of TRPM4 were fused to MBP and prepared by in vitro synthesis using transcription and translation-coupled rabbit reticulocyte lysates in the presence of Fig. 6B . Semiquantitatively, the darker the band, the stronger the binding of the fragment to CaM. Because many fragments showed positive binding to Ca 2ϩ -CaM in the initial screening, we have focused on the regions that displayed the relatively strongest binding. These experiments led to the identification of five CaM-binding sites on TRPM4: two sites located in the N terminus (E5/V25 and M186/R212), and three clustered in the C terminus (A1076/S1098, R1095/T1151, and E1146/E1176). Among them, fragment v (R1095/T1151) is rather unique in that it is much longer than most commonly found CaM-binding domains, which are typically ␣-helices of about 20 -30 amino acids. Shorter fragments were made from R1095/T1151, but they all failed to show a strong binding to Ca 2ϩ -CaM (Fig. 6B, right  panels) . Nevertheless, the N-terminal half, R1095/E1130 (fragment w), retained partial binding to CaM and was considered weakly positive. With the exception of the A1076/S1098 fragment, binding of CaM only occurred in the presence of Ca 2ϩ (Fig. 6C) . A1076/S1098 also binds CaM in the absence of Ca 2ϩ , but binding is strongly enhanced by addition of Ca 2ϩ . Next, we tested whether deletion of the CaM-binding sites affects TRPM4 activity. For both N-terminal deletion mutants ). The stars are data from the S1145A; filled squares are data from S1152A mutants in the presence of 1 M PMA and 4 mM ATP (the dotted line is an estimation by eye of the mutant data; points at 0.1 and 1 are 0 and 1, respectively, for both mutants). D, pooled data for current densities at ϩ100 mV at the peak of activation by 1 M Ca 2ϩ (n Ͼ 5 for all measurements). Note that the presence of ATP did not affect the peak current after breaking into the cell. For wild-type TRPM4, the current for 1 M Ca 2ϩ was significantly increased after preincubation with PMA; however, for the two mutants, there was no increase, indicating sensitization of TRPM4 by a PKC-dependent mechanism. A, time course of whole-cell current at ϩ100 mV (circles) and Ϫ100 mV (triangles) through TRPM4 during dialysis with 100 M Ca 2ϩ . Inducible HEK293 cells expressing FLAG-TRPM4 were used. The same protocol was employed as described in Fig. 2A . Pipette solutions contained 4 mM ATP, and MgCl 2 was added to reach 500 M free Mg 2ϩ (same calibration for both time courses). I-V curves below the time course were obtained from the times indicated by black and gray circles. B, the same protocol as described in A, but CaM 1,2,3,4 was expressed in the FLAG-TRPM4 cells. Similar, but much smaller, currents than described in A were activated (same values for all scale bars). C, pooled data of the peak current densities at ϩ100 mV activated by the dialysis of 10 and 100 M [Ca 2ϩ ] i . Data are from six controls and five CaM 1,2,3,4 -expressing cells. D, time course of TRPM4 activity in an excised patch exposed to 100 M Ca 2ϩ (the same protocol as described in Fig. 2C ; circles, ϩ100 mV; triangles, Ϫ100 mV). E, the same protocol as described in D, but in the presence of 10 M CaM. F, currents traces from the peak (black circle) and the steady state (star). The arrows indicate where the currents for the I Ϫ100mV /I ϩ100mV current ratio were measured. No CaM was applied. G, the same protocol as described in F, but 10 M CaM was present (calibration was the same as that described in F). H, pooled data showing the effect of CaM on the current ratio I Ϫ100mV /I ϩ100mV and the steady-state open probability at ϩ100 mV. Both values ( , with CaM; f, without CaM) were significantly increased by CaM (p Ͻ 0.05; n ϭ 8 for controls; n ϭ 10 for calmodulin).
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(⌬E5/V25 and ⌬M186/R211), whole-cell currents upon dialysis of 10 M Ca 2ϩ showed a similar activation time course as wild-type TRPM4. The shape of the I-V curves was also similar to that of the wild-type channels, and current densities were not significantly different (wild type, 165 Ϯ 47 pA/picofarad, n ϭ 6; ⌬E5/V25, 120 Ϯ 29 pA/picofarad, n ϭ 6; ⌬M186/R211, 99 Ϯ 39 pA/picofarad, n ϭ 5). In inside-out patches, the kinetics and Ca 2ϩ sensitivity of the ⌬E5/V25 and ⌬M186/R211 mutants were also similar (data not shown).
In contrast, deletion of the C-terminal CaM-binding sites strongly affected TRPM4 channel function (Fig. 7) . Truncation of the C terminus after Ala 1068 (A1068X), which eliminates all three sites, reduced the amplitude of Ca 2ϩ -activated currents to that of non-transfected cells. Truncation of the C terminus after Glu 1146 (E1146X), which only eliminated the last CaMbinding site, reduced current amplitudes by ϳ90% compared with wild-type TRPM4, without altering the biophysical properties of the channel (Fig. 7, A and B) . Disruption of individual sites (⌬A1076/S1098, ⌬R1095/E1130, or ⌬V1127/T1151) resulted in very small currents (Fig. 7C) . The ⌬E1146/E1176 deletion mutant had similar currents as the E1146X truncation (data not shown). The double mutant ⌬A1076/S1098-R1095/ E1130 was completely silent.
The most straightforward explanation of these results is that CaM is involved in Ca 2ϩ sensing of TRPM4. However, because the mutant channels were still activated by Ca 2ϩ , albeit to a lesser extent, it cannot be excluded that Ca 2ϩ activates TRPM4 directly and that CaM only plays a modulatory role. To test this possibility, we stimulated excised cell-free patches from all CaM mutants with Ca 2ϩ . Although the whole-cell currents were not resolvable from the background, we were still able to activate these TRPM4 deletion mutants in excised patches, albeit only at extremely positive potentials and very high Ca 2ϩ concentrations. Fig. 7 , D and E, shows an example for the deletion mutant ⌬E1146/E1176. Currents were activated in inside-out patches by 1000 M Ca 2ϩ . In control patches, a very FIG. 7 . Whole-cell current and currents from inside-out patches measured from deletion mutants of the C-terminal Ca 2؉ -CaM binding sites. A, time course of current at ϩ100 mV through wild-type TRPM4 dialyzed with 100 M Ca 2ϩ (whole-cell currents). The same protocol described in Fig. 2A was used to measure transiently transfected cells. The I-V curves measured at the marked point are shown to the right. B, the same protocol as described in A, but with the C-terminal truncation E1146X, which lacks the third C-terminal Ca 2ϩ -CaM binding site. Small currents were activated, which show, however, the same phenotype as wild-type currents. Similar small currents were obtained for the ⌬E1146/E1167 mutant. C, pooled data for the tested C-terminal mutants (n Ͼ 5 for all data). Current densities at ϩ100 mV at the peak of stimulation by 100 M Ca 2ϩ are shown. Mean current density for the mutants indicated by a star was Ͻ15 pA/picofarad. No current could be activated by the double deletion ⌬A1076/S1098-R1095/E1130, which is present in the membrane (see F). D, activation of currents through wild-type TRPM4 in inside-out patches. Current traces were obtained from 400-ms voltage steps between Ϫ100 and ϩ160 mV with an increment of ϩ20 mV from a holding potential of 0 mV in an inside-out patch exposed to 1000 M [Ca 2ϩ ] i . The I-V curve measured at the end of the step is plotted below the traces. Note that current activation starts at ϳ0 mV. E, protocol similar to that described in D, steps between Ϫ100 and ϩ200 mV with an increment of ϩ20 mV, but with ⌬E1146/1167. Current activation is shifted toward approximately ϩ100 mV. F, transiently transfected HEK293 cells expressing GFP-tagged wild-type TRPM4 and its C-terminal CaM-binding mutants were biotinylated on ice, washed, lysed, and precipitated with streptavidin-agarose. The amounts of TRPM4 and mutants in total cell lysates (top panel) and streptavidin-agarose precipitates (bottom panel) were determined by Western blotting using anti-GFP antibodies.
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large current can be measured at ϩ100 mV. For all deletion mutants of the three identified Ca 2ϩ -CaM binding sites, however, the current at ϩ100 mV was very small, and larger currents could only be activated at more positive potentials. This pattern was measured in all three CaM-deletion mutants (n ϭ 6 for ⌬A1076/S1098, ⌬R1095/E1130, and ⌬E1146/E1167) but absent in non-transfected cells (n ϭ 7). Also, among all C-terminal mutants, the largest currents were measured with the most distal ⌬E1146/E1176 mutant in the inside-out patches, consistent with the whole-cell data. However, these currents show a similar pattern as described for the deletion of putative ATP binding site, namely, an accelerated and complete decay (data not shown; five patches). All these findings indicate that Ca 2ϩ can still activate TRPM4, but its sensitivity is dramatically reduced by mutating the CaM-binding site or by structural changes in the C-terminal part of the channel that confers CaM binding.
In order to confirm that the mutant TRPM4 proteins were expressed on the plasma membrane, we performed a cell surface biotinylation assay using GFP-tagged TRPM4 constructs. As shown in Fig. 7F , similar levels of the wild-type and mutant GFP-TRPM4 fusion proteins were found in the crude cell lysates and in streptavidin-precipitated samples, indicating that the CaM-binding mutants did not affect the trafficking and translocation of TRPM4 to the plasma membrane. Thus, it is very likely that the C-terminal CaM-binding sites are essential for Ca 2ϩ sensing of TRPM4.
DISCUSSION
The TRPM4b channel is uncommon in as much as it is activated rather than inactivated by intracellular Ca 2ϩ and is impermeable to Ca 2ϩ . The molecular mechanisms involved in sensing intracellular Ca 2ϩ changes that lead to channel opening remain completely unknown. We show here for the first time that the Ca 2ϩ sensitivity of TRPM4 is regulated by ATP, PKC phosphorylation, and CaM.
ATP-One of the intriguing initial findings about the Ca 2ϩ sensitivity of TRPM4 was the large difference between wholecell and inside-out patch recordings in the Ca 2ϩ concentration required for half-maximal activation. We have shown that in excised patches, this value is almost 100 -5000 times higher than the value initially reported using the whole-cell configuration (Ref. 1; see also the corrected values in Ref. 18 ). In excised patches, the EC 50 values for activation of TRPM4 by Ca 2ϩ are about 30 times smaller immediately after patch excision than after reaching a "quasi"-stationary level (2) . This shift in EC 50 values suggests a time-dependent decrease in Ca 2ϩ sensitivity, which may be responsible for the fast decay of the current in the cell-free patches as well as in whole-cell recordings.
We show here that addition of ATP helps to restore the Ca 2ϩ sensitivity of TRPM4 in inside-out patches. TRPM4 recovered from desensitization when the cytoplasmic site of the membrane was exposed to a Ca 2ϩ -free solution containing Mg-ATP. After recovery, currents decay again in the absence of ATP. Interestingly, this recovery was strongly reduced in all mutants at putative ATP binding sites. This further supports the hypothesis that ATP plays an important role in maintaining the Ca 2ϩ sensitivity of the TRPM4 channels. More importantly, we show that all mutations that altered putative ATP binding sites on TRPM4 drastically accelerated channel desensitization to Ca 2ϩ . These findings indicate that at least a part of the Ca 2ϩ sensitivity of TRPM4 is restored through ATP binding directly to the channel protein.
An intriguing property of TRPM4 is that ATP can both block the channel and facilitate its activation. It is presently unclear whether the inhibitory site and the "facilitation" site are identical. Binding of ATP might not only block the channel but also prime it for reactivation. In the presence of Ca 2ϩ , ATP might be removed from the channel and allow channel opening and subsequent desensitization.
PKC Phosphorylation-We present evidence that the Ca 2ϩ sensitivity of TRPM4 is modulated by PKC-dependent phosphorylation. The phorbol ester PMA decreased the EC 50 value for TRPM4 activation by Ca 2ϩ from 15 to 4 M. This effect was abolished when either of the two C-terminal Ser residues predicted to have the highest score for PKC phosphorylation was mutated. It has been well described that PKC phosphorylation sensitizes several ion channels for agonist stimulation, e.g. activation of TRPV1 by capsaicin, heat, protons, or anandamide (19, 20) . A sensitizing effect of PKC stimulation on native TRPM4-like channels has been shown recently (21, 22 cannot fully substitute for Ca 2ϩ in TRPM4 activation (3) . A small activating effect of Sr 2ϩ has also been observed in the related TRPM5 channel, which has been interpreted as a possible direct effect on channel opening, rather than a CaM-dependent action, because CaM modulators did not affect TRPM5 activation (11) . However, our present results indicate that CaM sensitizes the affinity of the channel to Ca 2ϩ . First, expression of a dominant negative CaM mutant, in which all four EF-hand binding sites have been inactivated, decreases channel activation, although some Ca 2ϩ -dependent current activation remains. Second, direct application of CaM to the inner side of TRPM4 counteracts desensitization but does not fully prevent it. Third, mutations of C-terminal CaM-binding sites strongly reduce the current amplitude and promote rapid current decay, a hallmark of desensitization. In inside-out patches, currents through the TRPM4 CaM binding mutants can still be activated, although only at very high Ca 2ϩ concentrations and positive voltages. This situation is partly reminiscent of the gating of large conductance Ca 2ϩ -activated K ϩ channels, which open in the absence of Ca 2ϩ upon strong depolarization. Intracellular Ca 2ϩ shifts the activation curve toward negative potentials (30 -32) . As such, Ca 2ϩ allows channel activation to occur over the physiological range of membrane potentials. In a similar manner, CaM binding to the C terminus allows activation of TRPM4 to occur at more physiological voltages. However, in contrast to large conductance Ca 2ϩ -activated K ϩ channels, Ca 2ϩ binding is absolutely required for TRPM4 activation. Indeed, we failed to activate TRPM4 in the absence of Ca 2ϩ , even at extremely positive voltages. The presence of multiple CaM-binding sites on TRPM4 is intriguing. Using in vitro binding assays, we have identified five short regions, two at the N terminus and three at the C terminus of TRPM4, that interact with CaM in a Ca 2ϩ -dependent manner. All CaM-binding fragments showed much stronger association with CaM in the presence of Ca 2ϩ than in the absence of Ca 2ϩ , and only one region bound a detectable amount of CaM in the absence of Ca 2ϩ . These CaM-binding sites appear to be differentially involved in channel regulation because deletions of the C-terminal but not the N-terminal sites affected the Ca 2ϩ sensitivity of TRPM4. It is possible that 2 B. Nilius and J. Prenen, unpublished observations.
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the N-terminal CaM sites do not bind to CaM in the intact channel or, alternatively, that the N-terminal sites are involved in regulating other Ca 2ϩ -dependent functions not revealed by the current protocols. Nevertheless, our data strongly suggest that CaM binding to the C-terminal sites is vital for Ca 2ϩ sensitivity of TRPM4 in the physiological range of intracellular Ca 2ϩ concentrations as well as membrane potentials. It is worth noting that the three C-terminal CaM-binding sites are clustered in a relatively short region (ϳ92 amino acids) of TRPM4, only 33 amino acids downstream from the last transmembrane segment. This arrangement is reminiscent of the C-terminal CaM-binding domain of the type 2 small conductance Ca 2ϩ -activated K ϩ channel (SK2), which contains 77 amino acids (Asp 413 -Glu 489 ) and is ϳ15 residues downstream from the last transmembrane segment. Interestingly, the binding of SK2 to CaM involves three ␣-helices each from two SK2 subunits arranged as an antiparallel dimer that binds simultaneously to two CaM molecules (33) . Two helices bind to the C-terminal lobe, whereas the other one binds to the N-terminal lobe of CaM. This rather unique conformation differs from most other Ca 2ϩ -CaM/peptide structures, in which a single ␣-helix is embraced between the two lobes. At present, it is difficult to predict how CaM is bound to the C-terminal regions of TRPM4 in the absence of any structural information. The finding that disruption of any of the three CaM-binding sites dramatically decreased the Ca 2ϩ sensitivity of the TRPM4 channel implies that a conformation similar to SK2, involving three ␣-helices that bind simultaneously to one CaM, might exist for the association between CaM and TRPM4 C terminus. In line with this idea is our observation that the middle site is longer than usual and that deletion of either half of this site, ⌬R1095/E1130 or ⌬V1127/T1151, reduced the Ca 2ϩ sensitivity of the TRPM4 channel. In contrast to SK2 channels, in which two of the ␣-helices are constitutively bound to the C-terminal lobe of CaM independent of Ca 2ϩ (33, 34) , none of the CaM-binding sites in TRPM4 binds strongly to CaM in the absence of Ca 2ϩ . However, the weak Ca 2ϩ -independent interaction between CaM and A1076/S1098 may allow CaM to be constitutively associated with TRPM4 under resting conditions. Another difference with SK2 channels is that CaM binding to the C terminus does not appear to be essential for efficient expression of TRPM4 on the cell surface (35) .
In summary, we conclude from our results that the Ca 2ϩ sensitivity of TRPM4 is regulated by multiple factors. Activation by Ca 2ϩ is favored and desensitization is delayed when (a) Mg-ATP is bound, (b) the channel is phosphorylated by PKC, and (c) CaM is bound at a C-terminal region.
